Literature DB >> 10757070

Loss of heterozygosity in papillary and follicular thyroid carcinoma: a mini review.

J W Gillespie1, A Nasir, H E Kaiser.   

Abstract

Inactivation of tumor suppressor genes is an important mechanism in the development of most cancers. This can be detected by determining loss of heterozygosity (LOH) on highly polymorphic loci on chromosomes. Many investigations to determine LOH in papillary and follicular thyroid carcinoma have been performed using bulk tissue which was fresh, snap frozen, or has been formalin-fixed/paraffin-embedded. Loss of heterozygosity is more frequently encountered in follicular than papillary carcinoma. Laser Capture Microdissection (LCM) may be useful to ascertain if there is a pattern of LOH for various histologic forms and variants of thyroid carcinoma.

Entities:  

Mesh:

Year:  2000        PMID: 10757070

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  3 in total

1.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

2.  Differential expression profiling and functional analysis of microRNAs through stage I-III papillary thyroid carcinoma.

Authors:  Jing Zhang; Yang Liu; Zheng Liu; Xiao-Ming Wang; De-Tao Yin; Li-Li Zheng; De-Yan Zhang; Xiu-Bo Lu
Journal:  Int J Med Sci       Date:  2013-03-16       Impact factor: 3.738

3.  Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid Cancer: The Influence of DNA Repair Genes Variants.

Authors:  Luís S Santos; Octávia M Gil; Susana N Silva; Bruno C Gomes; Teresa C Ferreira; Edward Limbert; José Rueff
Journal:  Genes (Basel)       Date:  2020-09-17       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.